Antitumor effects of flavopiridol, a cyclin-dependent kinase inhibitor, on human cholangiocarcinoma in vitro and in an in vivo xenograft model
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Japan Student Services Organization
- Cholangiocarcinoma Research Institute, Khon Kaen University
- Ministry of Education, Culture, Sports, Science and Technology (IN60323)
- Khon Kaen University
This publication has 27 references indexed in Scilit:
- Tumor glycolysis as a target for cancer therapy: progress and prospectsMolecular Cancer, 2013
- Comparative Study of Human Hematopoietic Cell Engraftment into Balb/c and C57BL/6 Strain of Rag‐2/Jak3 Double‐Deficient MiceBioMed Research International, 2011
- 22‐Oxa‐1,25‐dihydroxyvitamin D3 efficiently inhibits tumor growth in inoculated mice and primary histoculutre of cholangiocarcinomaCancer, 2010
- Cholangiocarcinoma: lessons from ThailandCurrent Opinion in Gastroenterology, 2008
- Rhabdoid Tumor Growth is Inhibited by FlavopiridolClinical Cancer Research, 2008
- Increased expression of cyclin B1 sensitizes prostate cancer cells to apoptosis induced by chemotherapyMolecular Cancer Therapeutics, 2007
- Mcl-1 Mediates Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Resistance in Human Cholangiocarcinoma CellsCancer Research, 2004
- Investigating RNA polymerase II carboxyl‐terminal domain (CTD) phosphorylationEuropean Journal of Biochemistry, 2003
- Flavopiridol Inhibits Glycogen Phosphorylase by Binding at the Inhibitor SiteJournal of Biological Chemistry, 2000
- Flavopiridol Inhibits P-TEFb and Blocks HIV-1 ReplicationJournal of Biological Chemistry, 2000